745.36MMarket Cap-17.24P/E (TTM)
8.960High8.770Low62.54KVolume8.900Open8.690Pre Close553.90KTurnover0.08%Turnover RatioLossP/E (Static)84.80MShares10.45052wk High5.74P/B722.60MFloat Cap3.25052wk Low--Dividend TTM82.21MShs Float31.500Historical High--Div YieldTTM2.19%Amplitude0.600Historical Low8.856Avg Price1Lot Size
Anavex Life Sciences Stock Forum
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
hmmmmm 🤔 looks very similar throughout the market starting at 3 pm
No comment yet